Browsing: rinvoq

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

By KayeApril 7, 20220

The disease burden and current treatment landscape Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease with complex clinical manifestations…

Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)

By KayeMarch 17, 20220

Disease Burden and Current Treatment Landscape In June 2020, upadacitinib hemihydrate (Rinvoq; AbbVie), an oral reversible JAK1 selective inhibitor received…

About
Advertise
Contact Us
Privacy Policy

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

How TikTok’s Deadly ‘Blackout Challenge’ Puts Lives at Risk in Minutes

Recent Mooncake Recalls You Need to Know About

Updates on Kate Middleton’s Cancer Journey

Browsing: rinvoq

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)

How TikTok’s Deadly ‘Blackout Challenge’ Puts Lives at Risk in Minutes

Recent Mooncake Recalls You Need to Know About

Updates on Kate Middleton’s Cancer Journey

Healthcare communities unite at IHH Singapore Sea Regatta

Subscribe to Updates

What's Hot

Browsing: rinvoq

Subscribe to Updates